• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The combined evaluation of clinical and biochemical data in management of patients with differentiated thyroid cancer.

作者信息

Volpe Fabio, Piscopo Leandra

机构信息

Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.

出版信息

Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):230-232. doi: 10.1007/s00259-023-06387-x.

DOI:10.1007/s00259-023-06387-x
PMID:37552368
Abstract
摘要

相似文献

1
The combined evaluation of clinical and biochemical data in management of patients with differentiated thyroid cancer.分化型甲状腺癌患者管理中临床和生化数据的联合评估
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):230-232. doi: 10.1007/s00259-023-06387-x.
2
New opportunities for dosimetric approach in patients with differentiated thyroid cancer.分化型甲状腺癌患者剂量测定方法的新机遇。
Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):330-331. doi: 10.1007/s00259-023-06473-0.
3
Total thyroidectomy and synchronous video assisted lung metastasectomy in differentiated thyroid carcinoma.分化型甲状腺癌的全甲状腺切除术及同期电视辅助下肺转移瘤切除术
J Exp Clin Cancer Res. 1999 Jun;18(2):147-50.
4
Differentiated thyroid cancer: radioiodine following lobectomy - a clinical feasibility study.分化型甲状腺癌：肺叶切除术后放射性碘治疗——一项临床可行性研究。
Nucl Med Commun. 2004 Mar;25(3):245-51. doi: 10.1097/00006231-200403000-00006.
5
The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer.分化型甲状腺癌辅助放射性碘治疗中甲状腺床摄碘的定量评估与消退积聚之间的关系。
Ann Nucl Med. 2021 Feb;35(2):159-166. doi: 10.1007/s12149-020-01546-8. Epub 2021 Jan 2.
6
Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.甲状腺切除术后消融前血清甲状腺球蛋白水平联合消融后131I全身显像对分化型甲状腺癌患者成功消融的预测价值
Am J Clin Oncol. 2007 Feb;30(1):63-8. doi: 10.1097/01.coc.0000239138.64949.0a.
7
Differentiated thyroid carcinoma: Incremental diagnostic value of I SPECT/CT over planar whole body scan after radioiodine therapy.分化型甲状腺癌：放射性碘治疗后I SPECT/CT相对于平面全身扫描的增量诊断价值。
Endocrine. 2017 Jun;56(3):551-559. doi: 10.1007/s12020-016-1086-3. Epub 2016 Sep 29.
8
China is moving towards the standardised management of paediatric differentiated thyroid cancer.中国正朝着儿童分化型甲状腺癌的标准化管理迈进。
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):226-229. doi: 10.1007/s00259-023-06471-2. Epub 2023 Oct 13.
9
[The early detection of metastatic differentiated thyroid cancer using 131I total body scan and treatment with 131I].[利用¹³¹I全身扫描早期检测转移性分化型甲状腺癌及¹³¹I治疗]
Kaku Igaku. 1991 Mar;28(3):247-59.
10
Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.滤泡细胞源性甲状腺癌的管理：冈德森/路德医疗中心，1969年至1995年。
J Am Coll Surg. 1997 Oct;185(4):388-97.

本文引用的文献

1
Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer.低危分化型甲状腺癌患者消融治疗中放射性碘活度的短期和长期结果比较
Mol Imaging Radionucl Ther. 2023 Jun 20;32(2):112-116. doi: 10.4274/mirt.galenos.2022.05826.
2
Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma.甲状腺癌患者术后及放射性碘治疗前血清甲状腺球蛋白的预测作用
Cancers (Basel). 2023 May 30;15(11):2976. doi: 10.3390/cancers15112976.
3
Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer.
术后甲状腺球蛋白作为放射性碘治疗的衡量标准：1317 例分化型甲状腺癌欧洲多中心系列中的决策树分析。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2767-2774. doi: 10.1007/s00259-023-06239-8. Epub 2023 May 1.
4
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer.分化型甲状腺癌患儿治疗12个月反应的预后价值
Endocrine. 2023 Jun;80(3):612-618. doi: 10.1007/s12020-023-03309-7. Epub 2023 Jan 24.
5
Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.低危分化型甲状腺癌的当前争议：在过度诊断时代减少过度治疗。
J Clin Endocrinol Metab. 2023 Jan 17;108(2):271-280. doi: 10.1210/clinem/dgac646.
6
A semiquantitative study of the optimal whole-body imaging time after I therapy for differentiated thyroid cancer.分化型甲状腺癌碘治疗后最佳全身体位显像时间的半定量研究。
Front Endocrinol (Lausanne). 2022 Aug 25;13:955387. doi: 10.3389/fendo.2022.955387. eCollection 2022.
7
Functional and molecular thyroid imaging.功能性及分子甲状腺影像。
Q J Nucl Med Mol Imaging. 2022 Jun;66(2):86-92. doi: 10.23736/S1824-4785.22.03428-8. Epub 2022 Feb 15.
8
Functional imaging in thyroid cancer patients with metastases and therapeutic implications.甲状腺癌转移患者的功能成像及其治疗意义
Presse Med. 2022 Jun;51(2):104113. doi: 10.1016/j.lpm.2022.104113. Epub 2022 Feb 4.
9
Advances in Functional Imaging of Differentiated Thyroid Cancer.分化型甲状腺癌的功能成像进展
Cancers (Basel). 2021 Sep 23;13(19):4748. doi: 10.3390/cancers13194748.
10
Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer.通过实验室检查和影像学检查结果评估的分化型甲状腺癌患者治疗反应的长期预后价值
Cancers (Basel). 2021 Aug 27;13(17):4338. doi: 10.3390/cancers13174338.